Submission Details
| 510(k) Number | K122857 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 18, 2012 |
| Decision Date | November 07, 2012 |
| Days to Decision | 50 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Statement |
K122857 is an FDA 510(k) clearance for the HOPE CONTINUOUS NEBULIZER MODEL HOPE-11310, HEART NEBULIZER MODEL HEART-100609, THERAMIST NEBULIZER MODEL THERAMIST-3100, a Nebulizer (direct Patient Interface) (Class II — Special Controls, product code CAF), submitted by Pegasus Research Corp. (Costa Mesa, US). The FDA issued a Cleared decision on November 7, 2012, 50 days after receiving the submission on September 18, 2012. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.5630.
| 510(k) Number | K122857 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 18, 2012 |
| Decision Date | November 07, 2012 |
| Days to Decision | 50 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Statement |
| Product Code | CAF — Nebulizer (direct Patient Interface) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.5630 |